Skip to main content
Subscribe
Register
Sign in
Membership
Events
Knowledge Center
About
Subscribe
Register
Sign in
Premium
Alternative Insight and Premium Journalism
Latest Articles
Premium
Light Street Hits Turbulence in February as Tech Stocks Slide
Stephen Taub
March 4, 2026
Premium
Carl Icahn (Barely) Snaps a Six-Year Losing Streak
Stephen Taub
March 4, 2026
Premium
Greenlight Delivers Gains in a Losing Month for Stocks
Stephen Taub
March 2, 2026
Premium
Hedge Funds Capture Big Early Gains in Select Biotech IPOs — With One Notable Exception
Stephen Taub
February 26, 2026
Premium
Tiger Cubs Cash In as Stripe’s Valuation Takes Off
Stephen Taub
February 25, 2026
Premium
Caxton’s U.S. Stock Book Jumps 40 Percent as Law Adds Three New Mega Positions
Stephen Taub
February 24, 2026
Premium
CTAs Surge Ahead of Equity Markets as Metals‑Driven Trends Fuel January Gains
Stephen Taub
February 23, 2026
Premium
Stan Druckenmiller Piles Into Financials and Brazil as Health-Care Bets Fade
Stephen Taub
February 19, 2026
Premium
Lone Pine Offloads Meta in Rare One‑Quarter Exit
Stephen Taub
February 18, 2026
Premium
Light Street’s New Long Game
Stephen Taub
February 11, 2026
Premium
Viking Hybrid Fund Gains in the Fourth Quarter as Private Investment Strategy Slips
Stephen Taub
February 10, 2026
Premium
Third Point Overhauls Its Top Holdings in an Unusual Shake-Up
Stephen Taub
February 9, 2026
Premium
Haidar Kicks Off the Year With a Big Jump as Discovery Builds on Its Multi‑Year Tear
Stephen Taub
February 5, 2026
Premium
Bearish but Booming, David Einhorn’s Greenlight Starts 2026 With a Win
Stephen Taub
February 2, 2026
Premium
With a Thin IPO Calendar, Hedge Funds Are Zeroing In on Biopharma
Stephen Taub
January 29, 2026
Premium
The Tiger Grandcub Who Outsmarted the AI Frenzy
Stephen Taub
January 28, 2026
Premium
The Lowdown on High Ground’s Best Year
Stephen Taub
January 26, 2026
Premium
Robert Citrone’s Discovery Capital Scores a Three‑Year Run of Outsized Returns
Stephen Taub
January 22, 2026
More Articles